Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04358302 · ClinicalTrials.gov registry record · NA
Individual Patient Exposure and Response in Pediatric Lupus
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04358302 is a NA study that has completed, run by Duke University. The registered enrollment target is 26 participants.
The verdict
NCT04358302, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if an electronic pill bottle cap can help children and teens with systemic lupus better remember to take their medicine. It will also gather information on the best dose of hydroxychloroquine (Plaquenil®) for children and teens. Participants in this study will continue to take their usual medication as prescribed by their doctors. Participants will receive an electronic pill bottle cap, a smartphone, and a Fitbit. Over 6 months, a nurse will visit each participant 4 times to ask questions about symptoms, draw blood, and take a urine sample. After the study, participants will be able to keep the electronic pill bottle cap and Fitbit, but will return the smartphone.
Interventions
- BEHAVIORAL Pillsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2021-06-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04358302
The ClinicalTrials.gov registry entry for NCT04358302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pillsy is the first listed.
NCT04358302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04358302 about?
NCT04358302 is a clinical study titled "Individual Patient Exposure and Response in Pediatric Lupus". The purpose of this research study is to see if an electronic pill bottle cap can help children and teens with systemic lupus better remember to take their medicine. It will also gather information on the best dose of hydroxychloroquine (Plaquenil®) for children and teens. Participants in this study...
What is the current status of trial NCT04358302?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-09-28. Estimated completion is 2021-06-16.
What interventions are being tested in trial NCT04358302?
The interventions under investigation include: Pillsy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04358302?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.